Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer-Reference-Cited by-同舟云学术

Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer

Published:2021-11 Issue: Volume:227 Page:107870
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Islam Mohammad Kaisarul,Stanslas Johnson

Funder

Ministry of Higher Education, Malaysia

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference126 articles.

1. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes;Agata;International Immunology,1996

2. Tumour antigen-specific CD8 T cells infiltrating the tumour express high levels of PD-1 and are functionally impaired;Ahmadzadeh;Blood,2009

3. Aktoudianakis, E., Appleby, T., Cho, A. Du, Z., Graupe, M., Guerrero, J. A., … Ziebenhaus, C. A. (2018). PD-1/PD-L1 inhibitors. (US Patent Application US 20180305315 A1).

4. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: Mechanism, combinations, and clinical outcome;Alsaab;Frontiers in Pharmacology,2017

5. Combined cytotoxic chemotherapy and immunotherapy of cancer: Modern times;Bailly;NAR Cancer,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy;Molecular Cancer;2024-09-02

2. AUNP-12 Near-Infrared Fluorescence Probes across NIR-I to NIR-II Enable In Vivo Detection of PD-1/PD-L1 Axis in the Tumor Microenvironment;Bioconjugate Chemistry;2024-07-09

3. The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment;Cancer Letters;2024-07

4. A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules;Pharmaceuticals;2024-02-28

5. PD‐1: A critical player and target for immune normalization;Immunology;2024-01-25